Grant: Discovery Grants Program - Individual
Université de Montréal
$140,000.00
Studies in organic, bio-organic and medicinal chemistry
FY 2011-12
Summary
Organic Chemistry is the science that deals with living matter and the physiological processes that sustain survival. The synthesis of small organic molecules has been the foundation of the pharmaceutical industry having provided miracle drugs to combat a wide-cross section of diseases over many decades. Academic research has contributed to this process through basic work delineating the relationship between structure, property and function. In the process, excellent training is provided to young men and women who go on to contribute in a significant way to more target- and disease-oriented research in pharmaceutical and biotech companies with the objective of discovering better medicines. My research group at the University of Montreal has had a significant impact in the training of highly qualified personnel over the years. Among the nearly 300 group alumni are those who were responsible for the discovery and development of new and effective medicines with their respective companies. Those who have chosen an academic career have continued the tradition of excellence in training their own students. Over the years, my group has been involved in diverse areas of research that can be described as biology-inspired and chemically-driven. A particularly rewarding activity has been the synthesis of drug (i.e. medicinal agent) prototypes as proofs of concept with promising activities against cancer, cardiovascular disease, bacterial and viral infection, and Alzheimer's disease among others. Industrial collaborating partners have greatly benefitted from this.
In 1998, I was honoured as an Officer of the Order of Canada: The citation reads as follows: ""He has put Canadian science in the spotlight through his tremendous contribution to the fields of organic, medicinal, and carbohydrate chemistry. His unique computer programs are a fundamental tool used worldwide by chemists working in synthetic drug design, and his work on the creation of complex molecules has had immediate applications in the development of new drugs. His diligent and creative work in training hundreds of young scientists is one of many highlights of a stellar academic career.""
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
5511-2010
Name nom
Hanessian, Stephen
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
140000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
2
Nb partie
5
Application title
Studies in organic, bio-organic and medicinal chemistry
Keyword
NSERC
Application summary
Organic Chemistry is the science that deals with living matter and the physiological processes that sustain survival. The synthesis of small organic molecules has been the foundation of the pharmaceutical industry having provided miracle drugs to combat a wide-cross section of diseases over many decades. Academic research has contributed to this process through basic work delineating the relationship between structure, property and function. In the process, excellent training is provided to young men and women who go on to contribute in a significant way to more target- and disease-oriented research in pharmaceutical and biotech companies with the objective of discovering better medicines. My research group at the University of Montreal has had a significant impact in the training of highly qualified personnel over the years. Among the nearly 300 group alumni are those who were responsible for the discovery and development of new and effective medicines with their respective companies. Those who have chosen an academic career have continued the tradition of excellence in training their own students. Over the years, my group has been involved in diverse areas of research that can be described as biology-inspired and chemically-driven. A particularly rewarding activity has been the synthesis of drug (i.e. medicinal agent) prototypes as proofs of concept with promising activities against cancer, cardiovascular disease, bacterial and viral infection, and Alzheimer's disease among others. Industrial collaborating partners have greatly benefitted from this.
In 1998, I was honoured as an Officer of the Order of Canada: The citation reads as follows: ""He has put Canadian science in the spotlight through his tremendous contribution to the fields of organic, medicinal, and carbohydrate chemistry. His unique computer programs are a fundamental tool used worldwide by chemists working in synthetic drug design, and his work on the creation of complex molecules has had immediate applications in the development of new drugs. His diligent and creative work in training hundreds of young scientists is one of many highlights of a stellar academic career.""